Editing Drug design (section)

==Case studies==
{{div col|colwidth=20em}}
* [[5-HT3 antagonist#5-HT3 antagonists drug design|5-HT3 antagonists]]
* [[Nicotinic agonist|Acetylcholine receptor agonists]]
* [[Discovery and development of angiotensin receptor blockers|Angiotensin receptor antagonists]]
* [[Bcr-Abl tyrosine-kinase inhibitor]]s
* [[Cannabinoid receptor antagonist#Drug design|Cannabinoid receptor antagonists]]
* [[CCR5 receptor antagonist]]s
* [[Discovery and development of cyclooxygenase 2 inhibitors|Cyclooxygenase 2 inhibitors]]
* [[Development of dipeptidyl peptidase-4 inhibitors|Dipeptidyl peptidase-4 inhibitors]]
* [[Discovery and development of HIV protease inhibitors|HIV protease inhibitors]]
* [[NK1 receptor antagonist#Drug discovery and development|NK1 receptor antagonists]]
* [[Discovery and development of non-nucleoside reverse transcriptase inhibitors|Non-nucleoside reverse transcriptase inhibitors]]
* [[Discovery and development of nucleoside and nucleotide reverse-transcriptase inhibitors|Nucleoside and nucleotide reverse transcriptase inhibitors]]
* [[Discovery and development of phosphodiesterase 5 inhibitors|PDE5 inhibitors]]
* [[Discovery and development of proton pump inhibitors|Proton pump inhibitors]]
* [[Discovery and Development of Renin Inhibitors|Renin inhibitors]]
* [[Discovery and development of triptans|Triptans]]
* [[Discovery and development of TRPV1 antagonists|TRPV1 antagonists]]
* [[c-Met inhibitors]]
{{Div col end}}